Mutations in the endoplasmic reticulum chaperone protein CALR activate JAK2 signaling via pathogenic interaction with TPOR/MPL, and CALR mutations are causative in 25% of ET and PMF cases [107]. The gene discussed is MPL; the disease is essential thrombocythemia.